December 10, 2020

Multi-Center Evaluation of the Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Test

Category: Article Summary

Topic: Testing and Treatment

Keywords (Tags): testing

• Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV panel test showed high sensitivity and accuracy to distinguish SARS-CoV-2 from influenza and respiratory syncytial virus (RSV). Among 319 nasopharyngeal swab specimens (n=228 positive for SARS-CoV-2, influenza, or RSV; n=91 negative for all 3 infections), positive agreement for SARS-CoV-2 was 98.7% (n=74/75) and negative agreement was 100% (n=91), while all other pathogens showed 100% total agreement.

Mostafa et al. (Dec 9, 2020). Multi-Center Evaluation of the Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Test. Journal of Clinical Microbiology. https://doi.org/10.1128/JCM.02955-20